Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The total revenue at risk during this window is estimated to exceed $300 billion, with some projections reaching as high as $400 billion by 2033 as foundational patents for top-selling therapies like Keytruda, Eliquis, and Opdivo lapse
Since the newest drugs have proven so effective both at helping people lose weight and preventing other health problems doctors and policymakers want to expand access to GLP-1 medications
Annual Surveys at Nursing Facilities Are Essential To Protect Residents August 8, 2019 For decades, the nursing home industry has proposed relaxing the requirement for annual surveys at nursing facilities
EP oppositions can significantly impact the timeline for the generic launch of drugs
